NCT03917199View on ClinicalTrials.gov

Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

July 11, 2019

Conditions
Myocardial Perfusion ImagingComputed TomographyCoronary Artery Disease
Trial Locations (1)

04-628

Institute of Cardiology, Warsaw

All Listed Sponsors
collaborator

National Science Centre, Poland

OTHER_GOV

lead

National Institute of Cardiology, Warsaw, Poland

OTHER

NCT03917199 - Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study). | Biotech Hunter | Biotech Hunter